BlackWall
Blooms the Chemist
Haoma Mining
Moneytech
Pelathon
Planet Group Holdings
PrimaryMarkets
VGW Holdings
XYZ Ltd
Imugene
Genex Power
Capital Raises
Secondary Trading
.png)
News
Analyst Coverage
- 14 September 2018 - Bio Shares
- 16 August 2018 - Edison Research Note
- 22 January 2018 - BioWorld
- 6 June 2016 - Bioshares
- 18 April 2016 - Redchip Research Report
- 19 February 2016 - Edison Research Note
- 22 January 2016 - Bioshares
Media Coverage
- 26 March 2019 - OHIO STATE Oncology Update: Novel Anticancer Vaccine Shows Promise in Phase I Study - featuring our Scientific Advisory Board Member Professor Pravin Kaumaya, PhD.
- 7 January 2019 - Your Money - Chairman Paul Hopper interviewed on Trading Day.
- 17 December 2018 - Fierce Biotech - Imugene ‘encouraged’ by data for HER2 vaccine in gastric cancer
- 17 December 2018 - SMALL CAPS - Imugene’s Phase 1b HER-Vaxx cancer trial meets endpoints, reports positive results
- 17 December 2018 - STOCKHEAD - Imugene’s gastric cancer drug clears first safety hurdles
- 13 November 2018 - next BIOTECH - Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent
- 31 July 2018 - The Australian Financial Review - Why it’ll pay to be more open to biotech investment opportunities
- 6 June 2018 - The Australian Financial Review - Imugene to raise $20m, fund trials at Ohio State University, Mayo Clinic
- 14 May 2018 - The Australian - Biotech entrepreneur Hopper brings companies to life
- 7 April 2017 - The Australian Financial Review - New thinking answers call of progress
- 5 March 2017 - The Australian Business Review - Imugene CEO Leslie Chong: meet the unicorn leading the cancer fight
- 3 March 2017 - The Sydney Morning Herald - Breakthrough for local biotech as an influential backer emerges
- 22 April 2017 - Bionity.com - HER-Vaxx Re-formation shows dramatic ten-fold increase in Antibodies and early onset of response
- 20 April 2017 - Life Scientist - Imugene candidate increases cancer-fighting antibodies
Company Newsletters
- Newsletter - December 2018
- Newsletter - June 2018
- Newsletter - November 2017
- Newsletter - March 2017
Imugene Videos
- Imugene (ASX: IMU) KEY Vaxx B-cell Peptide Cancer Vaccine Technology 2019, March 5, 2019
- Imugene presenting all three immuno-oncology programs at AACR Annual Meeting, March 3 2019
- Imugene will present lead candidate HER-Vaxx at AACR Annual Meeting, February 27 2019
- Imugene adds key members to its scientific advisory board to advance company forward, January 11 2019
- Infinity Series with Imugene Chairman Paul Hopper ASX: IMU
- Imugene CEO Leslie Chong's Presentation at FNN Investor Event, October 23 2018
- Imugene (ASX:IMU) 1H18 results & outlook
- Imugene (ASX: IMU) Executive Chairman Paul Hopper TV interview on TICKY / YourMoney
- View MD/CEO Leslie Chong being interviewed by Commsec's Tom Piotrowski, June 13 2018
- View MD/CEO Leslie Chong being interviewed by Commsec's Tom Piotrowski, April 6 2018
- View Imugene Immuno-Oncology Expert Briefing featuring Dr Axel Hoos, Prof Dr Christoph Zielinski and Prof Dr Ursula Wiedermann
- CEO Leslie Chong interviewed by Finance News Network in October 2017
- CEO Leslie Chong interviewed by Edison TV in March 2017
